At KAN Research Institute, we conduct research to discover novel therapeutic concepts and medicines using the unique approach of “Integrative Cell Biology,” which focuses on the most fundamental unit of life, the “cell.”

information
more
2016.03.15
Coming Soon
topics
more
2016.06.13
Eisai has issued a news release about E6011, an anti-fractalkine antibody discovered in-house by KAN.